Trace Amine-Associated Receptor 1 (TAAR1) is a receptor found in brain regions important to neuropsychiatric conditions. TAAR1 has the potential to modulate neurotransmitters including dopamine, serotonin, and glutamate, and may be a novel therapeutic target for several conditions, including schizophrenia. To dive in deeper, take a look at this brief video.
The safety and efficacy of TAAR1 agents have not been reviewed or approved by any drug/medicine regulatory authority.
Sponsored by Sunovion Pharmaceuticals Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc.
MI-ULO-00098 April 2023